close
close

Eli Lilly: Sticking to $1,000 Price Target Ahead of Q3 Earnings, New Trading Range (NYSE: LLY)

Posted on by Vaseline
Eli Lilly: Sticking to ,000 Price Target Ahead of Q3 Earnings, New Trading Range (NYSE: LLY)

This article was written by

Mike Zaccardi, CFA, CMT profile photo

Freelance Financial Writer | Investments | Markets | Personal Finance | RetirementI write written content that is used in various formats including articles, blogs, emails and social media for financial advisors and investment firms in a cost-effective manner. My passion is to make financial data tell a story. I work with teams of senior editors, investment strategists, marketing managers, data analysts and executives, contributing ideas to make content relevant, accessible and measurable. With expertise in thematic investing, market events, client education and compelling investment outlooks, I can connect with everyday investors in a concise manner. I enjoy analyzing stock market sectors, ETFs, economic data and broad market conditions and then produce bite-sized content for different audiences. Macro drivers of asset classes such as equities, bonds, commodities, currencies and cryptos excite me. I enjoy communicating about finance in an educational and creative style. I also believe in producing evidence-based stories using empirical data to make points. Charts are one of the many tools I use to tell a story in a simple yet engaging way. I focus on SEO and specific style guides where appropriate.

Analyst Disclosure: I/we do not hold any shares, options or similar derivative positions in any of the companies mentioned, nor do we have any plans to take any such positions within the next 72 hours. This article is my own writing and my own opinion. I received no compensation for it (except from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha Disclosure: Past performance is not a guide to future results. No recommendation or advice is given as to whether a particular investment is suitable for a particular investor. Any opinions or views expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed dealer, broker, U.S. investment advisor or investment bank. Our analysts are third-party authors, including both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Related Posts